These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 30114278)

  • 1. PPARγ is reduced in the airways of non-CF bronchiectasis subjects and is inversely correlated with the presence of Pseudomonas aeruginosa.
    Burr LD; Rogers GB; Chen AC; Taylor SL; Bowler SD; Keating RL; Martin ML; Hasnain SZ; McGuckin MA
    PLoS One; 2018; 13(8):e0202296. PubMed ID: 30114278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Macrolide Treatment Inhibits Pseudomonas aeruginosa Quorum Sensing in Non-Cystic Fibrosis Bronchiectasis. An Analysis from the Bronchiectasis and Low-Dose Erythromycin Study Trial.
    Burr LD; Rogers GB; Chen AC; Hamilton BR; Pool GF; Taylor SL; Venter D; Bowler SD; Biga S; McGuckin MA
    Ann Am Thorac Soc; 2016 Oct; 13(10):1697-1703. PubMed ID: 27464029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adult non-cystic fibrosis bronchiectasis is characterised by airway luminal Th17 pathway activation.
    Chen AC; Martin ML; Lourie R; Rogers GB; Burr LD; Hasnain SZ; Bowler SD; McGuckin MA; Serisier DJ
    PLoS One; 2015; 10(3):e0119325. PubMed ID: 25822228
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of PPARγ and paraoxonase 2 correlated with Pseudomonas aeruginosa infection in cystic fibrosis.
    Griffin PE; Roddam LF; Belessis YC; Strachan R; Beggs S; Jaffe A; Cooley MA
    PLoS One; 2012; 7(7):e42241. PubMed ID: 22860094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition.
    Rogers GB; van der Gast CJ; Cuthbertson L; Thomson SK; Bruce KD; Martin ML; Serisier DJ
    Thorax; 2013 Aug; 68(8):731-7. PubMed ID: 23564400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of Major Pathogens from Sputum and Bronchoalveolar Lavage Fluid in Patients with Noncystic Fibrosis Bronchiectasis: A Systematic Review.
    Miao XY; Ji XB; Lu HW; Yang JW; Xu JF
    Chin Med J (Engl); 2015 Oct; 128(20):2792-7. PubMed ID: 26481748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis.
    Kapur N; Grimwood K; Masters IB; Morris PS; Chang AB
    Pediatr Pulmonol; 2012 Mar; 47(3):300-7. PubMed ID: 21901858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of bronchoscopy and bronchoalveolar lavage findings in three types of suppurative lung disease.
    de Vries JJV; Chang AB; Marchant JM
    Pediatr Pulmonol; 2018 Apr; 53(4):467-474. PubMed ID: 29405664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of long-term macrolide treatment on respiratory microbiota composition in non-cystic fibrosis bronchiectasis: an analysis from the randomised, double-blind, placebo-controlled BLESS trial.
    Rogers GB; Bruce KD; Martin ML; Burr LD; Serisier DJ
    Lancet Respir Med; 2014 Dec; 2(12):988-96. PubMed ID: 25458200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients.
    Luo RG; Miao XY; Luo LL; Mao B; Yu FY; Xu JF
    Clin Microbiol Infect; 2019 May; 25(5):601-606. PubMed ID: 30036669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total bacterial load, inflammation, and structural lung disease in paediatric cystic fibrosis.
    Taylor SL; Leong LEX; Ivey KL; Wesselingh S; Grimwood K; Wainwright CE; Rogers GB;
    J Cyst Fibros; 2020 Nov; 19(6):923-930. PubMed ID: 32199729
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel microbiota stratification system predicts future exacerbations in bronchiectasis.
    Rogers GB; Zain NM; Bruce KD; Burr LD; Chen AC; Rivett DW; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2014 May; 11(4):496-503. PubMed ID: 24592925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secreted mucins and airway bacterial colonization in non-CF bronchiectasis.
    Sibila O; Suarez-Cuartin G; Rodrigo-Troyano A; Fardon TC; Finch S; Mateus EF; Garcia-Bellmunt L; Castillo D; Vidal S; Sanchez-Reus F; Restrepo MI; Chalmers JD
    Respirology; 2015 Oct; 20(7):1082-8. PubMed ID: 26172851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UPR modulation of host immunity by Pseudomonas aeruginosa in cystic fibrosis.
    Bedi B; Lin KC; Maurice NM; Yuan Z; Bijli K; Koval M; Hart CM; Goldberg JB; Stecenko A; Sadikot RT
    Clin Sci (Lond); 2020 Jul; 134(14):1911-1934. PubMed ID: 32537652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced sputum compared to bronchoalveolar lavage in young, non-expectorating cystic fibrosis children.
    Blau H; Linnane B; Carzino R; Tannenbaum EL; Skoric B; Robinson PJ; Robertson C; Ranganathan SC
    J Cyst Fibros; 2014 Jan; 13(1):106-10. PubMed ID: 23806622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pseudomonas aeruginosa, cyanide accumulation and lung function in CF and non-CF bronchiectasis patients.
    Ryall B; Davies JC; Wilson R; Shoemark A; Williams HD
    Eur Respir J; 2008 Sep; 32(3):740-7. PubMed ID: 18480102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis.
    Taylor SL; Rogers GB; Chen AC; Burr LD; McGuckin MA; Serisier DJ
    Ann Am Thorac Soc; 2015 May; 12(5):701-7. PubMed ID: 25679336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of non-invasive modalities for assessing inflammation in patients with non-cystic fibrosis bronchiectasis.
    Tsikrika S; Dimakou K; Papaioannou AI; Hillas G; Thanos L; Kostikas K; Loukides S; Papiris S; Koulouris N; Bakakos P
    Cytokine; 2017 Nov; 99():281-286. PubMed ID: 28863927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunity and bacterial colonisation in bronchiectasis.
    Whitters D; Stockley R
    Thorax; 2012 Nov; 67(11):1006-13. PubMed ID: 21933944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lobar distribution in non-cystic fibrosis bronchiectasis predicts bacteriologic pathogen treatment.
    Izhakian S; Wasser WG; Fuks L; Vainshelboim B; Fox BD; Fruchter O; Kramer MR
    Eur J Clin Microbiol Infect Dis; 2016 May; 35(5):791-6. PubMed ID: 26873379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.